The group’s principle activities include research and developing therapeutic protein products. The group’s products are used to treatments on diseases include Acquired Immunodeficiency Syndrome (AIDS), Multiple sclerosis, Myasthenia gravis (MG), pain, and other viral disorders. The group operates from United States.
